01 1Sun Pharmaceutical Industries Limited
01 1DIVALPROEX SODIUM USP (PROCESS II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-12-20
Pay. Date : 2023-09-28
DMF Number : 38911
Submission : 2023-09-29
Status : Active
Type : II
20
Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DIVALPROEX SODIUM USP (PROCESS II), with a corresponding US DMF Number 38911.
Remarkably, this DMF maintains an Active status since its submission on September 29, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 20, 2023, and payment made on September 28, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
